This guide will help you answer 2.2. Explain reasons why medicines have generic and brand names.
Medicines are among the most important tools healthcare professionals use. Many medicines have a generic name and may also have one or more brand names. Understanding why this is the case helps health and social care workers make sure they administer medicines safely and efficiently.
The difference between generic and brand names exists because of the way medicines are developed, tested, and sold.
Development of Medicines
Medicines begin life in laboratories. Pharmaceutical companies research and develop new drugs to treat specific illnesses or conditions. During development, substances may have chemical names. A generic name is a standardised nonproprietary name for the active substance.
For example:
- Paracetamol is the generic name for a widely used pain-relief medication.
- Ibuprofen is the generic name for an anti-inflammatory and pain-relieving drug.
The generic name is usually complex and follows scientific rules. These rules are set by organisations such as the World Health Organization (WHO).
Once a medication is created, the company that developed it applies for a licence to sell it under a “brand name.” This is the name the company chooses to market the drug. Brand names are easier to pronounce and remember, making them more appealing to consumers and healthcare workers.
Examples include:
- Panadol, which is a brand name for paracetamol.
- Nurofen, which is a brand name for ibuprofen.
Drug Patents Explained
When a company creates a new drug, it files for a patent. A UK patent can protect a medicine-related invention for up to 20 years from the filing date. Brand names may be protected separately by trade marks. This prevents other companies from copying the drug and selling it for profit during the patent period.
Patents allow pharmaceutical companies to make money from their innovation. They spend millions developing new drugs, testing them through clinical trials, and getting them approved by regulatory bodies like the Medicines and Healthcare products Regulatory Agency (MHRA) in the UK. Without patents, companies might not be able to afford these costs.
Other companies can sell authorised generic versions when the relevant patent and other market protections allow. These generic versions must have the same active ingredients and work in the same way as the original. However, they are usually cheaper because they do not have the same research and development costs.
Marketing and Branding
Brand names are part of the pharmaceutical company’s marketing strategy. Companies choose names that are memorable, easy to say, and associate with the product’s benefits.
For example, “Nurofen” suggests relief from pain and inflammation. “Clarityn” implies clarity and relief from allergy symptoms.
Brand names often make the drug more recognisable to the public and healthcare professionals. Marketing through advertisements also contributes to the popularity of branded medicines. As a result, many patients prefer branded versions, even if their generic counterparts are equally effective.
Standardisation of Generic Names
Generic names are standardised. This means they stay the same regardless of which company produces the medicine. For example, paracetamol will always be referred to as paracetamol no matter which pharmacy sells it.
Standardisation is important for patient safety. Healthcare professionals depend on generic names to identify medications without the risk of confusion caused by multiple brand names.
For instance:
Accessibility and Affordability
Generic medicines are typically cheaper than branded ones. This is beneficial for patients, healthcare systems, and organisations such as the NHS, which aim to keep costs low while providing effective treatments.
Cheaper generic medicines make treatments more accessible, particularly for people on lower incomes. This helps reduce health inequalities and ensures more people get the medications they need.
The availability of generic medicines also benefits countries with limited resources. Governments can afford to buy large quantities of generic drugs to meet the needs of their population.
Efficacy and Safety
Generic medicines must meet high standards of safety, efficacy, and quality before being approved for use. Regulatory bodies like the MHRA require generic medicines to meet quality, safety and efficacy standards and demonstrate bioequivalence with a reference medicine.
While generic medicines may have different packaging or inactive ingredients (such as colourings or preservatives), some differences may matter for individual patients, for example if they have an allergy to an ingredient. This allows healthcare professionals to trust in their safety and reliability.
Differences in Appearance
Even though a generic medicine has the same active ingredient, it might look different from its branded counterpart. That is because the manufacturer of the generic drugs does not have to copy the branding or appearance of the original.
Tablets might vary in colour, size, or shape. Packaging may also look different. These variations do not impact the quality or effectiveness of the medication.
Communication and Clarity
The dual naming system of medicines can help improve communication between healthcare workers and patients. Generic names focus on the scientific aspect, which is vital for safe prescriptions and treatment planning.
Meanwhile, brand names often make discussions about medicine more straightforward for patients. People are more likely to remember names like “Nurofen” than “ibuprofen” because brand names are simpler and often use familiar language.
Healthcare workers often need to explain this distinction to patients. They might reassure patients that generic versions are just as effective as branded drugs and help them make cost-effective choices.
Final Thoughts
To summarise why medicines have generic and brand names:
- The generic name identifies the active substance and is internationally standardised.
- Brand names are used to identify and market medicines, including some off-patent products.
- Patents protect the company’s innovation during the drug’s early years on the market.
- Generic medicines can provide affordable alternatives when the relevant market protections allow them to be sold.
- Healthcare systems, including the NHS, save money by prescribing generic versions.
- Communication is improved by using both types of names.
Understanding these differences is crucial for health and social care workers. It helps ensure patient safety, encourages informed decisions, and supports efforts to make healthcare more affordable.